|Articles|December 1, 2002

December 2002
Volume 8
Issue 12

Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective

Author(s)Gregory de Lissovoy, PhD, Prasun Subedi, BS

Download PDF: Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective

Articles in this issue

about 23 years ago

Article

How Effectively Do Managed Care Organizations Influence Prescribing and Dispensing Decisions?

about 23 years ago

Article

Characteristics of Eye Care Practices With Managed Care Contracts

about 23 years ago

Article

Enhancing the Quality of Care for Patients With Coronary Heart Disease: The Design and Baseline Results of the Hastening the Effective Application of Research Through Technology (HEART) Trail

about 23 years ago

Article

When Do Developing Countries Adopt Managed Care Policies and Technologies? Part II: Infrastructure, Techniques, and Reform Strategies

about 23 years ago

Article

Profiling Resource Use: Do Different Outcomes Affect Assessments of Provider Efficiency?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

Prior Authorization Ranked Top Barrier to Health Care Access After Cost

FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film

Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024

Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD

FAQs About Glaucoma as Awareness Month Concludes